Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Key Takeaway: Charles River Laboratories has partnered with Eli Lilly's TuneLab to enhance their AI/ML platform by leveraging Charles River's expertise in nonclinical testing. This collaboration aims to optimize the integration of artificial intelligence and machine learning in drug development processes. The partnership reflects a growing trend in the biopharma industry to utilize advanced technologies for improving research outcomes.